Physician profile
Daniel Stephen White
NPI 1427060383
$813.02
in general payments reported to CMS, 2019-2025
11 companies · $34.45 in 2025
The $34.45 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $131 · 2021: $24.75 · 2022: $398 · 2023: $138 · 2024: $87.35 · 2025: $34.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $192.28 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $165.13 | 2022 | |
| Boston Scientific Corporation | $162.39 | 2019-2025 | Watchman Access System, Watchman |
| Abbott Laboratories | $138.54 | 2019-2022 | |
| Heartflow, INC. | $55.14 | 2023 | Ffrct |
| Biotronik INC. | $20.26 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $19.39 | 2022 | |
| Pfizer INC. | $19.11 | 2025 | |
| Novartis Pharmaceuticals Corporation | $15.96 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Amgen INC. | $12.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.